country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-191507

Copy Link Print Information

Lenalidomide-C6-COOH

Lenalidomide-C6-COOH (Compound 9.3) is an E3 ligase-linker conjugate. Lenalidomide-C6-COOH can be used to synthesize PROTACs, such as PROTAC CDK9 degrader-16 (HY-191173).

For research use only. We do not sell to patients.

CAS No.: 2411021-55-9
Formula: C₂₀H₂₄N₂O₅
Molecular Weight:372.41

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (276 KB)

Lenalidomide-C6-COOH Chemical Structure

CAS No.: 2411021-55-9

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- In Vitro
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

Lenalidomide-C6-COOH (Compound 9.3) is an E3 ligase-linker conjugate. Lenalidomide-C6-COOH can be used to synthesize PROTACs, such as PROTAC CDK9 degrader-16 (HY-191173)^[1].

All E3 Ligase Ligand-Linker Conjugates Isoforms :

In Vitro

PROTAC stands for proteolysis-targeting chimeras, a type of heterobifunctional small-molecule compound whose structure contains two different ligands: one is a ubiquitin ligase E3 ligand, and the other is a ligand that binds to the target protein in cells. The two ligands are connected by a linker, thereby forming a "three-body" polymer-target protein ligand-Linker-E3 ligand. PROTACs specifically degrade target proteins through the "ubiquitin-proteasome" pathway by bringing the target protein and the intracellular E3 ubiquitin ligase closer together. PROTACs can improve the druggability of "undruggable" targets.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS No. 2411021-55-9
Molecular Weight 372.41
Formula C₂₀H₂₄N₂O₅
SMILES

OC(CCCCCCC1=C2CN(C3CCC(NC3=O)=O)C(C2=CC=C1)=O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (276 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Chen X, et al. Degradation agents for cyclin dependent kinase, preparation method therefor, pharmaceutical composition thereof and use thereof. WO 2020/035049 A1. Published 2020 Feb 20.

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote